Beijing Strong Biotechnologies, Inc.

Shenzhen Stock Exchange 300406.SZ

Beijing Strong Biotechnologies, Inc. Operating Income for the year ending December 31, 2023: USD 83.65 M

Beijing Strong Biotechnologies, Inc. Operating Income is USD 83.65 M for the year ending December 31, 2023, a 26.73% change year over year. Operating income is the profit earned by a company from its normal business operations before interest and taxes are deducted.
  • Beijing Strong Biotechnologies, Inc. Operating Income for the year ending December 31, 2022 was USD 66.00 M, a -21.74% change year over year.
  • Beijing Strong Biotechnologies, Inc. Operating Income for the year ending December 31, 2021 was USD 84.34 M, a 259.69% change year over year.
  • Beijing Strong Biotechnologies, Inc. Operating Income for the year ending December 31, 2020 was USD 23.45 M, a -56.78% change year over year.
  • Beijing Strong Biotechnologies, Inc. Operating Income for the year ending December 31, 2019 was USD 54.25 M, a 7.43% change year over year.
Key data
Date Operating Income EBIT EBITDA Net Income
Market news
SV Wall Street
Shenzhen Stock Exchange: 300406.SZ

Beijing Strong Biotechnologies, Inc.

CEO Mr. Xi Liu
IPO Date Oct. 30, 2014
Location China
Headquarters Kuang Yi Building
Employees 1,094
Sector Healthcare
Industries
Biotechnology 3D Printing Cleaning Supplies Clinical Trials Medical Instruments Personal Care Pharmaceuticals Plastics
Description

Beijing Strong Biotechnologies, Inc. provides in-vitro diagnostics products and services in the People's Republic of China and internationally. It offers clinical biochemistry products, such as reagents and automatic biochemistry analyzers; coagulation products, including reagents and automated coagulation analyzers; and serology products comprising blood type test cards and automated blood grouping analyzers. The company was founded in 2001 and is headquartered in Beijing, the People's Republic of China.

StockViz Staff

February 3, 2025

Any question? Send us an email